1NHALER
"1NHALER" is a trademark owned by 1nhaler Limited, filed at the WIPO on February 24, 2026. It is on file and covers classes 3, 5 and 10.
- Status
- Mixed
- Filed
- February 24, 2026
- Registered
- Not yet
- Expires
- February 24, 2036
- Application no.
- Not recorded
- Registration no.
- 1926148
- Office
- WIPO
- World Intellectual Property Organization
- Mark type
- Trademark
- 3 classes
Who owns 1NHALER
The owner and representative on file with the office.
Owner
1nhaler Limited
United Kingdom
Representative
HGF Limited
HGF Limited
What the mark covers
The products and services 1NHALER is filed for, grouped by Nice class.
Cosmetics; functional cosmetics; cosmetic powders; non-medicated cleansing agents for internal use; non-medicated cleansers for wellness purposes; non-medicated cleansers for personal use, namely, lung cleansers; cleansing sprays.
Pharmaceutical preparations; drug delivery agents; pharmaceutical and chemical preparations for delivery through respiratory devices; pharmaceutical preparations and compounds for treating respiratory disorders, human allergies, anaphylaxis, fungal infections, viral infections, anxiety disorders, panic disorders, eating disorders, asthma, COPD, nicotine addiction, drug addiction, alcohol addiction, cystic fibrosis, depression, diabetes, epilepsy, erectile dysfunction, HIV, symptoms of menopause, migraines, motor neurone disease, symptoms associated with motor neurone disease, multiple sclerosis, myocardinal infarction, cardiac disorders, nausea, opioid abuse, pain, Parkinson's disease, pulmonary arterial hypertension, post-partum haemorrhage, sleeping disorders, malaria, cholera, diphtheria, anthrax, tetanus, hepatitis A, hepatitis B, influenza, measles, meningitis, polio, rabies, pneumonia, rotavirus, smallpox, typhoid, yellow fever, tuberculosis, lung cancer, cancers, chronic coughs, bronchitis, non-cystic fibrosis bronchiectasis, mucus buildup, obesity, cerebrovascular accidents and HPV; pharmaceutical preparations, namely rescue medications; pharmaceutical preparations, namely, antibiotics; pharmaceutical preparations, namely, nicotine replacement compounds; respiratory stimulants; pharmaceutical preparations for the treatment of respiratory, neurological, hormonal and immune system related diseases and disorders; biological preparations for medical purposes; antiserums for diagnostic purposes; diagnostic reagents and diagnostic markers for medical purposes in the fields of respiratory disorders, human allergies, anaphylaxis, fungal infections, viral infections, anxiety disorders, panic disorders, eating disorders, asthma, COPD, nicotine addiction, drug addiction, alcohol addiction, cystic fibrosis, depression, diabetes, epilepsy, erectile dysfunction, HIV, menopause, migraines, motor neurone disease, multiple sclerosis, myocardinal infarction, cardiac disorders, nausea, opioid abuse, pain, Parkinson's disease, pulmonary arterial hypertension, post-partum haemorrhage, sleeping disorders, malaria, cholera, diphtheria, anthrax, tetanus, hepatitis A, hepatitis B, influenza, measles, meningitis, polio, rabies, pneumonia, rotavirus, smallpox, typhoid, yellow fever, tuberculosis, lung cancer, cancers, chronic coughs, bronchitis, non-cystic fibrosis bronchiectasis, mucus buildup, obesity, cerebrovascular accidents and HPV; diagnostic reagents for medical purposes in the field of rescue medications; diagnostic reagents and contrast media for medical use; antibodies for medical purposes; assays for medical use; immune cells for medical purposes; antigen tests for use in the diagnosis and treatment of respiratory disorders, human allergies, anaphylaxis, fungal infections, viral infections, anxiety disorders, panic disorders, eating disorders, asthma, COPD, nicotine addiction, drug addiction, alcohol addiction, cystic fibrosis, depression, diabetes, epilepsy, erectile dysfunction, HIV, symptoms of menopause, migraines, motor neurone disease, symptoms associated with motor neurone disease, multiple sclerosis, myocardinal infarction, cardiac disorders, nausea, opioid abuse, pain, Parkinson's disease, pulmonary arterial hypertension, post-partum haemorrhage, sleeping disorders, malaria, cholera, diphtheria, anthrax, tetanus, hepatitis A, hepatitis B, influenza, measles, meningitis, polio, rabies, pneumonia, rotavirus, smallpox, typhoid, yellow fever, tuberculosis, lung cancer, cancers, chronic coughs, bronchitis, non-cystic fibrosis bronchiectasis, mucus buildup, obesity, cerebrovascular accidents and HPV; vaccine therapeutic preparations; homeopathic pharmaceuticals.
Medical devices; inhalers; nasal inhalers; nasal sprays; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; drug delivery systems; single use dry powder drug delivery device; metered dose drug delivery device; dry powder inhalers; medical apparatus for facilitating the inhalation of pharmaceutical preparations; medical apparatus for the treatment of respiratory disorders, human allergies, anaphylaxis, fungal infections, viral infections, anxiety disorders, panic disorders, eating disorders, asthma, COPD, nicotine addiction, drug addiction, alcohol addiction, cystic fibrosis, depression, diabetes, epilepsy, erectile dysfunction, HIV, symptoms of menopause, migraines, motor neurone disease, symptoms associated with motor neurone disease, multiple sclerosis, myocardinal infarction, cardiac disorders, nausea, opioid abuse, pain, Parkinson's disease, pulmonary arterial hypertension, post-partum haemorrhage, sleeping disorders, malaria, cholera, diphtheria, anthrax, tetanus, hepatitis A, hepatitis B, influenza, measles, meningitis, polio, rabies, pneumonia, rotavirus, smallpox, typhoid, yellow fever, tuberculosis, lung cancer, cancers, chronic coughs, bronchitis, non-cystic fibrosis bronchiectasis, mucus buildup, obesity, cerebrovascular accidents and HPV; inhalers for the treatment of respiratory disorders, human allergies, anaphylaxis, fungal infections, viral infections, anxiety disorders, panic disorders, eating disorders, asthma, COPD, nicotine addiction, drug addiction, alcohol addiction, cystic fibrosis, depression, diabetes, epilepsy, erectile dysfunction, HIV, symptoms of menopause, migraines, motor neurone disease, symptoms associated with motor neurone disease, multiple sclerosis, myocardinal infarction, cardiac disorders, nausea, opioid abuse, pain, Parkinson's disease, pulmonary arterial hypertension, post-partum haemorrhage, sleeping disorders, malaria, cholera, diphtheria, anthrax, tetanus, hepatitis A, hepatitis B, influenza, measles, meningitis, polio, rabies, pneumonia, rotavirus, smallpox, typhoid, yellow fever, tuberculosis, lung cancer, cancers, chronic coughs, bronchitis, non-cystic fibrosis bronchiectasis, mucus buildup, obesity, cerebrovascular accidents and HPV; drug delivery systems for nicotine replacement therapies; apparatus for the alleviation and treatment of breathing difficulties; apparatus for administering drugs by inhalation; drug delivery devices sold empty, namely inhalers; membranes for filtration for use with medical devices; respiratory sensors; sensors for medical use to gather human biometric data; measuring devices for medical use; parts and fittings for all the aforesaid goods.
About 1NHALER
Who owns the trademark "1NHALER"?
The WIPO trademark "1NHALER" is owned by 1nhaler Limited.
What is the status of "1NHALER"?
Its status at the WIPO is: mixed.
Get this data via the API
Everything on this page comes from the Signa API. Pull 1NHALER and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_c2144ab9-cca2-43d1-b97d-f5c026388333
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_c2144ab9-cca2-43d1-b97d-f5c026388333",
"object": "trademark",
"mark_text": "1NHALER",
"status": {
"primary": "mixed",
"stage": "mixed"
},
"office_code": "WO",
"application_number": null,
"filing_date": "2026-02-24",
"nice_classes": [
3,
5,
10
],
"owners": [
{
"name": "1nhaler Limited",
"entity_id": null
}
]
}